<?xml version="1.0" encoding="UTF-8"?>
<p>A derivative of celecoxib based a benzo[b]furan moiety was reported to demonstrate selective activity against COX-2. Besides, new molecules containing rhodanine and benzofuran scaffolds were designed, synthesized, and reported to exhibit dual COX-2, and 5-LOX inhibitory potential [
 <xref rid="B39-molecules-25-03726" ref-type="bibr">39</xref>,
 <xref rid="B40-molecules-25-03726" ref-type="bibr">40</xref>]. A recent patent survey reported a review focused on benzofuran inhibitors [
 <xref rid="B41-molecules-25-03726" ref-type="bibr">41</xref>,
 <xref rid="B42-molecules-25-03726" ref-type="bibr">42</xref>].
</p>
